| 1 |
34738630 | Androgen deprivation‑induced OPHN1 amplification promotes castration‑resistant prostate cancer. | 2022 Jan |
3 |
| 2 |
35196489 | A genome-scale CRISPR screen reveals PRMT1 as a critical regulator of androgen receptor signaling in prostate cancer. | 2022 Feb 22 |
2 |
| 3 |
35326387 | Analyzing the Androgen Receptor Interactome in Prostate Cancer: Implications for Therapeutic Intervention. | 2022 Mar 9 |
3 |
| 4 |
35390118 | Targeting the androgen receptor signaling pathway in advanced prostate cancer. | 2022 Apr 7 |
4 |
| 5 |
35553247 | Decisions and dilemmas in non-metastatic castration-resistant prostate cancer management. | 2022 May 13 |
1 |
| 6 |
35579577 | Factors that guide selection among androgen receptor inhibitors in patients with nonmetastatic castration-resistant prostate cancer. | 2022 May |
2 |
| 7 |
32847482 | Is the duration of castration resistance predictive for sequential treatment responses in the metastatic castration-resistant prostate cancer setting? | 2021 Sep |
1 |
| 8 |
33316417 | First-line systemic therapy for metastatic castration-sensitive prostate cancer: An updated systematic review with novel findings. | 2021 Jan |
1 |
| 9 |
33357209 | MicroRNA Regulation of Androgen Receptor in Castration-Resistant Prostate Cancer: Premises, Promises, and Potentials. | 2021 Oct 25 |
5 |
| 10 |
33477370 | Resistance to Antiandrogens in Prostate Cancer: Is It Inevitable, Intrinsic or Induced? | 2021 Jan 17 |
1 |
| 11 |
33672769 | An Overview of Next-Generation Androgen Receptor-Targeted Therapeutics in Development for the Treatment of Prostate Cancer. | 2021 Feb 20 |
1 |
| 12 |
33750894 | Orphan nuclear receptors as regulators of intratumoral androgen biosynthesis in castration-resistant prostate cancer. | 2021 Apr |
2 |
| 13 |
33807106 | Cross-Resistance to Abiraterone and Enzalutamide in Castration Resistance Prostate Cancer Cellular Models Is Mediated by AR Transcriptional Reactivation. | 2021 Mar 23 |
2 |
| 14 |
33981146 | Treatment Strategies for Metastatic Castration-Sensitive Prostate Cancer: From "All-Comers" to "Personalized" Approach. | 2021 |
2 |
| 15 |
34129460 | Using darolutamide in advanced prostate cancer: How I Do It. | 2021 Jun |
1 |
| 16 |
34193246 | A novel DNA methylation signature is associated with androgen receptor activity and patient prognosis in bone metastatic prostate cancer. | 2021 Jun 30 |
1 |
| 17 |
34536356 | Androgen-deprivation induced senescence in prostate cancer cells is permissive for the development of castration-resistance but susceptible to senolytic therapy. | 2021 Nov |
1 |
| 18 |
34584218 | Prostate cancer castrate resistant progression usage of non-canonical androgen receptor signaling and ketone body fuel. | 2021 Nov |
2 |
| 19 |
34680353 | Second-Generation Jak2 Inhibitors for Advanced Prostate Cancer: Are We Ready for Clinical Development? | 2021 Oct 17 |
1 |
| 20 |
34692685 | The Role of Androgen Receptor in Cross Talk Between Stromal Cells and Prostate Cancer Epithelial Cells. | 2021 |
1 |
| 21 |
32276264 | AR-dependent phosphorylation and phospho-proteome targets in prostate cancer. | 2020 Jun |
2 |
| 22 |
32477465 | Nucleolin represses transcription of the androgen receptor gene through a G-quadruplex. | 2020 May 12 |
1 |
| 23 |
32485222 | Mithramycin suppresses DNA damage repair via targeting androgen receptor in prostate cancer. | 2020 Sep 28 |
1 |
| 24 |
32560654 | Early upregulation of AR and steroidogenesis enzyme expression after 3 months of androgen-deprivation therapy. | 2020 Jun 19 |
5 |
| 25 |
32631766 | Combination Androgen Receptor Inhibition and Docetaxel in Metastatic Castration-sensitive Prostate Cancer: The Next Step in First-line Treatment? | 2020 Dec |
1 |
| 26 |
32708219 | Ralaniten Sensitizes Enzalutamide-Resistant Prostate Cancer to Ionizing Radiation in Prostate Cancer Cells that Express Androgen Receptor Splice Variants. | 2020 Jul 21 |
2 |
| 27 |
32765070 | Darolutamide: An Evidenced-Based Review of Its Efficacy and Safety in the Treatment of Prostate Cancer. | 2020 |
1 |
| 28 |
32900627 | Update on cardiovascular and metabolic risk profiles of hormonal agents used in managing advanced prostate cancer. | 2020 Dec |
2 |
| 29 |
33795928 | Pictet-Spengler condensations using 4-(2-aminoethyl)coumarins. | 2020 Aug 21 |
2 |
| 30 |
30224544 | Targeting the MIF/CXCR7/AKT Signaling Pathway in Castration-Resistant Prostate Cancer. | 2019 Jan |
3 |
| 31 |
30639309 | Auranofin lethality to prostate cancer includes inhibition of proteasomal deubiquitinases and disrupted androgen receptor signaling. | 2019 Mar 5 |
1 |
| 32 |
30692044 | Preclinical study using androgen receptor (AR) degradation enhancer to increase radiotherapy efficacy via targeting radiation-increased AR to better suppress prostate cancer progression. | 2019 Feb |
2 |
| 33 |
30742064 | Protein Kinase N1 control of androgen-responsive serum response factor action provides rationale for novel prostate cancer treatment strategy. | 2019 Jun |
2 |
| 34 |
30771738 | Adjuvant androgen deprivation therapy for poor-risk, androgen receptor-positive salivary duct carcinoma. | 2019 Mar |
4 |
| 35 |
30775248 | Potential impact of combined inhibition of 3α-oxidoreductases and 5α-reductases on prostate cancer. | 2019 Jan |
1 |
| 36 |
30871130 | Suppressive Role of Androgen/Androgen Receptor Signaling via Chemokines on Prostate Cancer Cells. | 2019 Mar 13 |
1 |
| 37 |
31110158 | BRD4 Regulates Metastatic Potential of Castration-Resistant Prostate Cancer through AHNAK. | 2019 Aug |
1 |
| 38 |
31239713 | Androgen upregulates the palmitoylation of eIF3L in human prostate LNCaP cells. | 2019 |
2 |
| 39 |
31484364 | Loss of Fibroblast-Dependent Androgen Receptor Activation in Prostate Cancer Cells is Involved in the Mechanism of Acquired Resistance to Castration. | 2019 Sep 3 |
3 |
| 40 |
31900916 | Androgen Receptor Dependence. | 2019 |
2 |
| 41 |
28353036 | Resistance to Hormonal Therapy in Prostate Cancer. | 2018 |
2 |
| 42 |
28413979 | Drug Resistance of Enzalutamide in CRPC. | 2018 |
1 |
| 43 |
29134684 | Enhanced radiosensitization of enzalutamide via schedule dependent administration to androgen-sensitive prostate cancer cells. | 2018 Jan |
3 |
| 44 |
29272069 | Androgen deprivation therapy for androgen receptor-positive advanced salivary duct carcinoma: A nationwide case series of 35 patients in The Netherlands. | 2018 Mar |
1 |
| 45 |
29276148 | Testosterone Diminishes Cabazitaxel Efficacy and Intratumoral Accumulation in a Prostate Cancer Xenograft Model. | 2018 Jan |
3 |
| 46 |
29425687 | ASC-J9® suppresses prostate cancer cell invasion via altering the sumoylation-phosphorylation of STAT3. | 2018 Jul 1 |
2 |
| 47 |
29477409 | Androgen deprivation therapy-induced epithelial-mesenchymal transition of prostate cancer through downregulating SPDEF and activating CCL2. | 2018 May |
1 |
| 48 |
29966326 | A hnRNP K⁻AR-Related Signature Reflects Progression toward Castration-Resistant Prostate Cancer. | 2018 Jun 30 |
3 |
| 49 |
29967592 | Androgen Receptor-CaMKK2 Axis in Prostate Cancer and Bone Microenvironment. | 2018 |
1 |
| 50 |
30242112 | Downregulation of Dipeptidyl Peptidase 4 Accelerates Progression to Castration-Resistant Prostate Cancer. | 2018 Nov 15 |
1 |